Latest KFF Health News Content

Latest KFF Health News Stories

Preeminent Hospitals Penalized Over Rates Of Patients’ Injuries

KFF Health News Original

Medicare cut payments for 786 hospitals because of high infection and complication rates. They included a third of the hospitals proclaimed as the nation’s best in one prominent ranking.

Masks Reveal Cultural Disconnect As L.A.’s Chinese Community Braces For Coronavirus

KFF Health News Original

Since two cases of the mysterious new coronavirus were reported in Southern California, Chinese immigrants have begun donning face masks. The practice is common in China but goes against official guidance in the U.S., and that’s causing conflict in local schools.

KHN’s ‘What The Health?’: Remaking Medicaid — Maybe

KFF Health News Original

The Trump administration is proposing to let states have more control of their Medicaid programs in exchange for potentially less money from the federal government. Meanwhile, the dangerous respiratory virus spreading from China is starting to affect trade and transportation along with public health. Kimberly Leonard of the Washington Examiner, Erin Mershon of Stat and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss this and more.

What To Know About Purdue Pharma Legal Fight: Bankruptcy Negotiations, Kickback Schemes And Lawsuits, Oh My!

Morning Briefing

Reuters, which broke news Tuesday about an alleged kickback scheme possibly involving the OxyContin manufacturer, breaks down the current legal charges the company faces. News on the epidemic is on prescription guidelines and a lack of followup care for teens, as well.

Investors Nervous About Anthem’s Medical Loss Ratio As Insurer Forecasts Earnings Below Expectations

Morning Briefing

Anthem said its medical loss ratio was 89% in the fourth quarter, higher than the 88.1% figure that a consensus of analysts had estimated. Investors closely watch the MLR as a gauge of health spending and insurers’ operational profitability. In other health industry news: short-term plans, Walmart’s bet on primary care, job cuts, worker shortages, and more.

Drug Prices Will See More Moderate Increase But Specialty Million-Dollar Therapies Still Driving Costs Higher

Morning Briefing

“Hospitals and patients are still getting killed by new million-dollar drugs that won’t see any competition for decades,” said Dan Kistner, group senior vice president of pharmacy solutions for Vizient. In other pharmaceutical news: Roche posts its growth report, Novartis’ gene therapy for infants continues to perform well, CVS figures out a way to help with diabetes medication costs, and scientists dig into the phenomenon of biotech’s “missing girls.”

What’s Billed As Quick, Easy Procedure To Fix Heavy Periods Turns Into Nightmare For Many Patients

Morning Briefing

MedPage Today investigates the fallout from selling patients on an endometrial ablation with a NovaSure device. Now thousands of women in the U.S. and around the world are taking to Facebook groups and online petitions saying their ablation led to serious issues, and trying to warn others about their experience.

While Other Dems Bicker, Bloomberg Goes For Tried-And-True Achilles Heel: Pre-Existing Conditions Coverage

Morning Briefing

Although Democrats’ plans to expand the health system have dominated much of the 2020 primary season, what has worked for voters in the past is reminding them of popular provisions from the health law that Republicans are chipping away at. Michael Bloomberg is seizing the opportunity to own that messaging. Meanwhile, Sen. Bernie Sanders (I-Vt.) is facing more questions about paying for “Medicare for All” as new polls show its losing popularity in battleground states.

Invisible War Wounds Like Traumatic Brain Injuries Often Overlooked But Can Be Devastating

Morning Briefing

Traumatic brain injuries were recently thrust into the national spotlight after President Donald Trump downplayed the seriousness of the problem. Experts say that’s common for the injuries that can’t be seen. In other public health news: lung-cancer screenings, lab-grown “mini-brains,” airplane safety, chronic inflammation, and fitness apps.

Life Expectancy Rises In U.S. For First Time In Four Years As Overdose Fatalities, Cancer Deaths Decline

Morning Briefing

While life expectancy ticked up by the tiniest of margins from 78.6 to 78.7 years, health researchers warned that U.S. had a lower life expectancy than 10 other wealthy nations. News also focuses on maternal mortality rates.

Public Health Experts Warn About A Dangerous Symptom Of Coronavirus: Xenophobia

Morning Briefing

“More panic, more temptation to blame the outsider — the other,” says Robert Fullilove, a professor of sociomedical sciences at New York’s Columbia University Medical Center. Fullilove is among the experts who are warning that mass hysteria over the coronavirus could lend itself to bigotry and baseless fear.

With Dueling Epidemics, Fights Over Stem Cells And Cannabis, Politically Tricky Waters Await New FDA Commissioner

Morning Briefing

New FDA Commissioner Stephen Hahn has a sterling reputation in the medical field, but little government experience. That could effect his ability to navigate the barrage of public health crises currently gripping the country.

Hospital Star Ratings Get Refresh Despite Pushback From Industry That Methodology Is Flawed

Morning Briefing

CMS Administrator Seema Verma said in a statement that the ratings were refreshed using the existing methodology because “the American people deserve up-to-date information on how hospitals are performing.”